Short-term Type-1 diabetes differentially modulates 14-3-3 proteins in rat brain and liver

European Journal of Clinical Investigation

Volumn 44, Issue 4, 2014, Pages 350-358

  Taurino, Federica ^a   Stanca, Eleonora ^b   Vonghia, Luisa ^a   Siculella, Luisa ^b   Sardanelli, Anna Maria ^a,c   Papa, Sergio ^d   Zanotti, Franco ^a   Gnoni, Antonio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

^c INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^d CNR   (Italy)

Author keywords

14 3 3 proteins; Brain; Diabetes; Liver; Streptozotocin; Type 1 diabetes

Indexed keywords

MESSENGER RNA; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 ETA; PROTEIN 14 3 3 GAMMA; PROTEIN 14 3 3 THETA; PROTEIN 14 3 3 ZETA; STRATIFIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; CYTOSOL; CYTOSOLIC FRACTION; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; WESTERN BLOTTING;

14-3-3 PROTEINS; BRAIN; DIABETES; LIVER; STREPTOZOTOCIN; TYPE-1 DIABETES;

14-3-3 PROTEINS; ANIMALS; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; LIVER; MALE; RATS, WISTAR; RNA, MESSENGER;

EID: 84895930382     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12241     Document Type: Article

References (41)

1. Kleppe R, Martinez A, Døskeland SO, Haavik J. The 14-3-3 proteins in regulation of cellular metabolism. Semin Cell Dev Biol 2011;22:713-19.
2. Obsil T, Obsilova V. Structural basis of 14-3-3 protein functions. Semin Cell Dev Biol 2011;22:663-72.
3. Benzinger A, Popowicz GM, Joy JK, Majumdar S, Holak TA, Hermeking H. The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization. Cell Res 2005;15:219-27.
4. Aitken A. Post-translational modification of 14-3-3 isoforms and regulation of cellular function. Semin Cell Dev Biol 2011;22:673-80.
5. Foote M, Zhou Y. 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol 2012;3:152-64.
6. MacKay RK, Colson NJ, Dodd PR, Lewohl JM. Differential expression of 14-3-3 isoforms in human alcoholic brain. Alcohol Clin Exp Res 2011;35:1041-9.
7. Liang S, Shen G, Liu Q, Xu Y, Zhou L, Xiao S et al. Isoform-specific expression and characterization of 14-3-3 proteins in human glioma tissues discovered by stable isotope labeling with amino acids in cell culture-based proteomic analysis. Proteomics Clin Appl 2009;3:743-53.
8. Liang S, Xu Y, Shen G, Liu Q, Zhao X, Xu Z et al. Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis 2009;30:4152-62.
9. Cao WD, Zhang X, Zhang JN, Yang ZJ, Zhen HN, Cheng G et al. Immunocytochemical detection of 14-3-3 in primary nervous system tumors. J Neurooncol 2006;77:125-30.
10. Liu Y, Tian RF, Li YM, Liu WP, Cao L, Yang XL et al. The expression of seven 14-3-3 isoforms in human meningioma. Brain Res 2010;1336:98-102.
11. Qi W, Liu X, Qiao D, Martinez JD. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 2005;113:359-63.
12. Yang X, Cao W, Lin H, Zhang W, Lin W, Cao L et al. Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J Neurol Sci 2009;276:54-9.
13. Fernyhough P, Chowdhury SKR, Schmidt RE. Mitochondrial stress and the pathogenesis of diabetic neuropathy. Expert Rev Endocrinol Metab 2010;5:39-49.
14. Taurino F, Stanca E, Siculella L, Trentadue R, Papa S, Zanotti F et al. Mitochondrial proteome analysis reveals depression of the Ndufs3 subunit and activity of complex I in diabetic rat brain. J Proteomics 2012;75:2331-41.
15. Sima AA, Zhang W, Muzik O, Kreipke CW, Rafols JA, Hoffman WH. Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide. Rev Diabet Stud 2009;6:211-22.
16. Sima AA. Encephalopathies: the emerging diabetic complications. Acta Diabetol 2010;47:279-93.
17. Hernandez-Fonseca JP, Rincon J, Pedreanez A, Viera N, Jose L. Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats. Exp Diabetes Res 2009;2009:329632.
18. Francés DE, Ronco MT, Monti JA, Ingaramo PI, Pisani GB, Parody JP et al. Hyperglycemia induces apoptosis in rat liver through the increase of hydroxyl radical: new insights into the insulin effect. J Endocrinol 2010;205:187-200.
19. Ogihara T, Isobe T, Ichimura T, Taoka M, Funaki M, Sakoda H et al. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J Biol Chem 1997;272:25267-74.
20. Xiang X, Yuan M, Song Y, Ruderman N, Wen R, Luo Z. 14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1. Mol Endocrinol 2002;16:552-62.
21. Thandavarayan RA, Watanabe K, Ma M, Veeraveedu PT, Gurusamy N, Palaniyandi SS et al. 14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. Biochem Pharmacol 2008;75:1797-806.
22. Sari FR, Watanabe K, Thandavarayan RA, Harima M, Zhang S, Muslin AJ et al. 14-3-3 protein protects against cardiac endoplasmic reticulum stress (ERS) and ERS-initiated apoptosis in experimental diabetes. J Pharmacol Sci 2010;113:325-34.
23. Yohannes E, Chang J, Tar MT, Davies KP, Chance MR. Molecular targets for diabetes mellitus-associated erectile dysfunction. Mol Cell Proteomics 2010;9:565-78.
24. Like AA, Rossini AA. Streptozotocin induced pancreatic insulitis: new model of diabetes mellitus. Science 1976;193:415-17.
25. Damiano F, Rochira A, Tocci R, Alemanno S, Gnoni A, Siculella L. hnRNP A1 mediates the activation of the IRES-dependent SREBP-1a mRNA translation in response to endoplasmic reticulum stress. Biochem J 2013;449:543-53.
26. Priore P, Stanca E, Gnoni GV, Siculella L. Dietary fat types differently modulate the activity and expression of mitochondrial carnitine/acylcarnitine translocase in rat liver. Biochim Biophys Acta 2012;1821:1341-9.
27. Larionov A, Krause A, Miller W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 2005;6:62.
28. van Hemert MJ, Niemantsverdriet M, Schmidt T, Backendorf C, Spaink HP. Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3 sigma and 14-3-3 zeta. J Cell Sci 2004;117:1411-20.
29. Brunet A, Kanai F, Stehn J, Xu J, Sarbassova D, Frangioni JV et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol 2002;156:817-28.
30. Wilker E, Yaffe MB. 14-3-3 Proteins 14-3-3 a focus on cancer and human disease. J Mol Cell Cardiol 2004;37:633-42.
31. Huang N, Marie SK, Livramento JA, Chammas R, Nitrini R. 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology 2003;61:354-7.
32. Martínez-Yélamos A, Saiz A, Sanchez-Valle R, Casado V, Ramón JM, Graus F et al. 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis. Neurology 2001;57:722-4.
33. Zhao J, Meyerkord CL, Du Y, Khuri FR, Fu H. 14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol 2011;22:705-12.
34. Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ. Joslin's Diabetes Mellitus, 14th edn. Boston: Lippincott Williams & Wilkins, 2005.
35. Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003;4:752-62.
36. Umahara T, Uchihara T, Nakamura A, Iwamoto T. Isoform-dependent immunolocalization of 14-3-3 proteins in developing rat cerebellum. Brain Res 2009;1253:15-26.
37. Hong SW, Qi W, Brabant M, Bosco G, Martinez JD. Human 14-3-3 gamma protein results in abnormal cell proliferation in the developing eye of Drosophila melanogaster. Cell Div 2008;3:2.
38. Ko BS, Lai IR, Chang TC, Liu TA, Chen SC, Wang J et al. Involvement of 14-3-3γ overexpression in extrahepatic metastasis of hepatocellular carcinoma. Hum Pathol 2011;42:129-35.
39. Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D. 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation. J Biol Chem 2004;279:34353-60.
40. Satoh J, Tabunoki H, Nanri Y, Arima K, Yamamura T. Human astrocytes express 14-3-3 sigma in response to oxidative and DNA-damaging stresses. Neurosci Res 2006;56:61-72.
41. Ge Q, Huang N, Wynn RM, Li Y, Du X, Miller B et al. Structural characterization of a unique interface between carbohydrate response element-binding protein (ChREBP) and 14-3-3β protein. J Biol Chem 2012;287:41914-21.